BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28013188)

  • 1. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
    Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
    Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris.
    Degani G; Barbiroli A; Magnelli P; Digiovanni S; Altomare A; Aldini G; Popolo L
    Glycoconj J; 2019 Feb; 36(1):27-38. PubMed ID: 30612271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why.
    Mol M; Degani G; Coppa C; Baron G; Popolo L; Carini M; Aldini G; Vistoli G; Altomare A
    Redox Biol; 2019 May; 23():101083. PubMed ID: 30598328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved expression system for the VC1 ligand binding domain of the receptor for advanced glycation end products in Pichia pastoris.
    Degani G; Colzani M; Tettamanzi A; Sorrentino L; Aliverti A; Fritz G; Aldini G; Popolo L
    Protein Expr Purif; 2015 Oct; 114():48-57. PubMed ID: 26118699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin is a binding partner of the human receptor of advanced glycation end products.
    Degani G; Altomare A; Digiovanni S; Arosio B; Fritz G; Raucci A; Aldini G; Popolo L
    J Biol Chem; 2020 Aug; 295(35):12498-12511. PubMed ID: 32665403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
    Chiou JW; Fu B; Chou RH; Yu C
    PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
    Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
    Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
    Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
    Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
    Yatime L; Andersen GR
    FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.
    Kennel SJ; Williams A; Stuckey A; Richey T; Wooliver C; Chazin W; Stern DA; Martin EB; Wall JS
    Amyloid; 2016; 23(1):8-16. PubMed ID: 26701064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
    Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
    Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
    Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
    Sung HY; Dowarha D; Chou RH; Yu C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
    Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
    J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processes.
    Serratos IN; Castellanos P; Pastor N; Millán-Pacheco C; Rembao D; Pérez-Montfort R; Cabrera N; Reyes-Espinosa F; Díaz-Garrido P; López-Macay A; Martínez-Flores K; López-Reyes A; Sánchez-García A; Cuevas E; Santamaria A
    PLoS One; 2015; 10(3):e0120221. PubMed ID: 25757085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
    Teissier T; Boulanger É
    Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end product recognition by the receptor for AGEs.
    Xue J; Rai V; Singer D; Chabierski S; Xie J; Reverdatto S; Burz DS; Schmidt AM; Hoffmann R; Shekhtman A
    Structure; 2011 May; 19(5):722-32. PubMed ID: 21565706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
    Dattilo BM; Fritz G; Leclerc E; Kooi CW; Heizmann CW; Chazin WJ
    Biochemistry; 2007 Jun; 46(23):6957-70. PubMed ID: 17508727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE).
    Buyannemekh D; Nham SU
    Mol Cells; 2017 May; 40(5):355-362. PubMed ID: 28535664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
    Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
    Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.